In order to strengthen international exchanges and cooperation in the field of stem cell research and treatment, and promote the efficient transformation and application of cutting-edge results in stem cells and regenerative medicine, The 6th International Symposium on Human Pluripotent Stem Cell Research and Treatment （Pluripotent Stem Cell Conference 2026, PSConf 2026）与 The first academic conference of the Asian Stem Cell and Regenerative Medicine Alliance (AASCRM Inaugural Summit) will be Co-organized at the Beijing International Convention Center from October 9 to 11, 2026 。
PSConf–AASCRM 2026 conference with“ Pathways to Organ Regeneration: State of the art in underpinning science and technology ”As the theme, it focuses on the three main lines of cutting-edge scientific research, alliance strategic dialogue and international organization collaboration. It sets up multiple academic forums around the basic science of organ regeneration, complex system insights of stem cells and organoids, the large-scale stem cell engineering and the clinical transformation of stem cell therapy. It systematically discusses the key technological breakthroughs and transformation paths of human pluripotent stem cells and their derivative drugs from research and development to application. This conference will comprehensively present the entire chain of innovation progress from basic frontiers to translational applications, and is committed to creating a high-end academic and strategic collaboration platform linking the Asian and global stem cell fields.
At the level of international collaboration, the conference will simultaneously promote high-level consultations on two major international academic platforms: First, the ISCA International Organization closed-door strategic meeting, which will include ISSCR，ISCT，ISO/TC276，ISCBI，ISCI，hPSC reg High-level representatives from international organizations and other international organizations will conduct international collaborative dialogues on solving the key challenges of stem cell medicine.； The second is the AASCRM closed-door strategic meeting. Stem cell society presidents and representatives from member countries such as China, Japan, South Korea, Singapore, Australia and New Zealand will have in-depth discussions on topics such as alliance cooperation framework, joint research, policy coordination and education promotion. In addition, the Asian Stem Cell Alliance Leadership Forum and Young Scientists Forum will bring together heads of member societies and regional outstanding young scholars to build a cooperation network and talent echelon.
The lineup of speakers for the conference has all been confirmed. Leading scholars and clinical translation experts from China, the United States, the United Kingdom, Australia, Japan, South Korea, Singapore, Canada, Switzerland, Spain, Norway, Germany and other countries and regions have been invited. The speakers cover the world's top institutions and transformation frontiers. Representatives of international organizations include the President of the Korean Stem Cell Society (KSSCR), the President of the Australia-New Zealand Society for Stem Cell Research (ASSCR), the President of the Singapore Stem Cell Society (SCSS), the Scientific Director of the International Society for Stem Cell Research (ISSCR), and the CEO of the International Society for Stem Cell Research (ISSCR). There are many highlights of this conference: high-level participation from international organizations, the first academic conference of the Asian Stem Cell Alliance was officially held, cutting-edge science and translational applications were closely integrated, and young scientists and leadership forums jointly built a talent echelon.
This conference is hosted by the Beijing Institute of Stem Cells and Regenerative Medicine (BISCRM), the National Key Laboratory of Organ Regeneration and Intelligent Manufacturing, Institute of Zoology, Chinese Academy of Sciences (ORR-IOZ_CAS), the International Stem Cell Alliance (ISCA), the Asian Alliance of Stem Cells and Regenerative Medicine (AASCRM), and the Stem Cell Biology Branch of the Chinese Society of Cell Biology (CSSC). R), Chinese Society of Cell Biology Standards Working Committee (SC-CSCB), Beijing Keqiao Charity Foundation (KF), China Stem Cell and Regenerative Medicine Collaborative Innovation Platform (CASCRM), National Stem Cell Resource Bank (NSCRC), co-organized by Beijing Zuixin Science and Technology Co., Ltd., and in cooperation with the European Commission Human Pluripotent Stem Cell Registration Center (hPSC) reg ), International Stem Cell Bank Initiative (ISCBI), International Stem Cell Initiative (ISCI) and other international organizations jointly present an open, cutting-edge, cross-regional academic event.
The conference will build an efficient and professional communication platform for global scientific researchers, industries and policy makers, focusing on the latest achievements and application prospects of transforming human pluripotent stem cell research into health solutions. This is not only an academic feast for the exchange of ideas and knowledge sharing, but also an important opportunity to expand international horizons, stimulate cross-border innovation, and jointly shape the future of stem cells and regenerative medicine.
meeting time
International Symposium on Human Pluripotent Stem Cell Research and Treatment
October 9-10, 2026
The first academic conference of the Asian Stem Cell and Regenerative Medicine Alliance
October 11, 2026
Meeting location and size
Location: Beijing International conference center
(No. 8, Beichen East Road, Chaoyang District)
Size: 800 people
Main members of the conference organization
Overview of speakers and conference agenda
Registration
The deadline for online registration is October 7. Please complete registration through the official website of the conference and pay the corresponding conference registration fee before then. You can also apply for an electronic invoice. In addition, the conference also provides on-site registration services for your choice. Registration fees are as follows:
Note: The registration fee includes the participation materials fee for the two conferences and lunch and coffee breaks during the conference. You are responsible for transportation, accommodation and other expenses yourself.
To register for the conference, please log in to the official website of the conference (https://2026psconf.tiemeeting.com) and click “Register Now” to start online registration. You can also scan the QR code below to register. Please fill in the registration information in detail. Due to limited seats, on-site participants must fill in the specific attendance date.
Contact information
Conference Secretary:
Lin Yin
psconf@biscrm.ac.cn
Conference registration technical support:
Tang Qianmin
naomitang@healife.com
Phone: 15316352569
International Symposium on Human Pluripotent Stem Cell Research and Treatment
PSConf
The International Symposium on Human Pluripotent Stem Cell Research and Treatment (Pluripotent Stem Cell Conference, PSConf) is a high-end academic and strategic collaboration conference initiated by the Beijing Institute of Stem Cell and Regenerative Medicine and co-sponsored by more than ten international organizations, societies and institutions, including the International Stem Cell Alliance (ISCA) and the Institute of Zoology, Chinese Academy of Sciences. The conference adheres to the "3C" principle of "Consultation, Collaboration, and Coordination", takes the exploration of full-chain innovation from basic frontiers to translational applications as the benchmark, and aims to solve the core common problems in field development. Through multi-party collaboration between academia, clinical medicine, industry and regulatory agencies, the conference promotes the standardization construction of basic research, clinical trials, industrial transformation, industry supervision and other aspects.
A major feature of the conference is the "Bridging Session" of international organizations. More than ten international stem cell-related organizations have reached consensus on issues such as field collaboration, resource sharing, international standards, data interoperability, and ethical supervision, and promoted in-depth cross-border, cross-organization, and cross-disciplinary cooperation.
The first conference will be held in Beijing in 2021. It is held annually and brings together authoritative experts in the field of stem cells from more than 20 countries including China, the United States, the United Kingdom, France, Germany, Switzerland, Sweden, Japan, South Korea, Singapore, Australia, and New Zealand. It has now become an annual academic event with international influence in the field of stem cells and regenerative medicine.
Asian Stem Cell and Regenerative Medicine Alliance
AASCRM
The Asian Alliance for Stem Cells and Regenerative Medicine (AASCRM) was jointly initiated and established in 2019 by the Stem Cell Branch of the Chinese Society of Cell Biology (CSSCR), the Japanese Society of Regenerative Medicine (JSRM) and the Korean Stem Cell Society (KSSCR). The Stem Cell Society of Singapore (SCSS) will join in 2021, and the Australian and New Zealand Stem Cell Society (ASSCR) will join in 2025. The alliance aims to build a cooperation network in the field of stem cells and regenerative medicine in Asia and promote joint research, policy coordination and education promotion.
On October 11, 2026, the first academic conference of AASCRM will be held concurrently with the 6th PSConf in Beijing. Stem cell society presidents and representatives from member countries such as China, Japan, South Korea, Singapore, and Australia will gather in Beijing. The conference will include an alliance leadership forum and a young scientist forum, bringing together heads of member societies and regional outstanding young scholars to build a cooperation network and talent echelon.
Number
023-68059937
Email：Jinfeng@jflab.ac.cn
Address:
No.313, Bella Road Chongqing High-tech Zone
Postal code: 401329
渝公网安备50009802002274